Efficacy of initial triple combination therapy with metformin, dapagliflozin and saxagliptin in drug-naive patients with type 2 diabetes: a randomised controlled trial

被引：0
|
作者：
Kim, N. [1 ]
Kim, J. [2 ]
Moon, J. [3 ]
Lee, Y. -H. [4 ]
Kim, T. [5 ]
Cho, H. [6 ]
Kwak, S. [7 ]
Lim, S. [8 ]
Kim, D. [9 ]
Moon, M. [10 ]
Kim, S. [11 ]
机构：
[1] Korea Univ, Internal Med, Coll Med, Seoul, South Korea
[2] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Seoul, South Korea
[3] Yeungnam Univ, Coll Med, Daegu, South Korea
[4] Yonsei Univ, Coll Med, Seoul, South Korea
[5] Seoul Med Ctr, Seoul, South Korea
[6] Keimyung Univ, Sch Med, Deagu, South Korea
[7] Seoul Natl Univ Hosp, Seoul, South Korea
[8] Seoul Natl Univ, Bundang Hosp, Seongnam, South Korea
[9] Konkuk Univ, Coll Med, Seoul, South Korea
[10] Seoul Natl Univ, Bundang Hosp, Seoul, South Korea
[11] Korea Univ, Coll Med, Seoul, South Korea
来源：
DIABETOLOGIA | 2023年 / 66卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
285
引用
收藏
页码：S151 / S151
页数：1
相关论文
共 50 条
  • [21] Effects of gemigliptin versus sitagliptin or glimepiride on glycaemic variability as initial combination therapy with metformin in drug-naive patients with type 2 diabetes
    Lee, B. -W.
    Kim, J.
    Park, S.
    Jung, C.
    Lee, S. -H.
    Suh, S.
    Lee, W.
    Cho, J. -H.
    Jang, Y.
    Kim, S. -H.
    Park, C. -Y.
    [J]. DIABETOLOGIA, 2015, 58 : S387 - S387
  • [22] Efficacy and safety of triple therapy with dapagliflozin add-on to saxagliptin plus metformin over 52 weeks in patients with type 2 diabetes
    Mathieu, C.
    Herrera Marmolejo, M.
    Gonzalez Gonzalez, J. G.
    Hansen, L.
    Chen, H.
    Johnsson, E.
    Garcia-Sanchez, R.
    Iqbal, N.
    [J]. DIABETES OBESITY & METABOLISM, 2016, 18 (11): : 1134 - 1137
  • [23] Randomized, Double-Blind Trial of Triple Therapy With Saxagliptin Add-on to Dapagliflozin Plus Metformin in Patients With Type 2 Diabetes
    Matthaei, Stephan
    Catrinoiu, Doina
    Celinski, Aleksander
    Ekholm, Ella
    Cook, William
    Hirshberg, Boaz
    Chen, Hungta
    Iqbal, Nayyar
    Hansen, Lars
    [J]. DIABETES CARE, 2015, 38 (11) : 2018 - 2024
  • [24] Combination therapy with saxagliptin and dapagliflozin for the treatment of type 2 diabetes
    Williams, David M.
    Stephens, Jeffrey W.
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (15) : 2373 - 2379
  • [25] Efficacy and Safety of Linagliptin/Metformin Fixed-Dose Combination (FDC) as Initial Therapy in Drug-Naive Asian Patients with Type 2 Diabetes (T2D)
    Pan, Changyu
    Mu, Yiming
    Fan, Bei
    Hehnke, Uwe
    Gong, Yan
    [J]. DIABETES, 2015, 64 : A323 - A323
  • [26] Efficacy and tolerability of initial combination therapy with nateglinide and metformin in treatment-naive patients with type 2 diabetes
    Horton, ES
    Foley, JE
    Shen, SG
    Baron, MA
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2004, 20 (06) : 883 - 889
  • [27] Efficacy of vildagliptin in drug-naive patients with type 2 diabetes
    Dejager, S.
    Baron, M. A.
    Razac, S.
    Foley, J. E.
    Dickinson, S.
    Schweizer, A.
    [J]. DIABETOLOGIA, 2006, 49 : 479 - 480
  • [28] Saxagliptin given in combination with metformin as initial therapy improves glycaemic control in patients with type 2 diabetes compared with either monotherapy: a randomized controlled trial
    Jadzinsky, M.
    Pfuetzner, A.
    Paz-Pacheco, E.
    Xu, Z.
    Allen, E.
    Chen, R.
    [J]. DIABETES OBESITY & METABOLISM, 2009, 11 (06): : 611 - 622
  • [29] Randomised, double-blind trial of dual add-on saxagliptin plus dapagliflozin vs saxagliptin or dapagliflozin add-on alone in poorly controlled type 2 diabetes on metformin
    Hansen, L.
    Zee, P.
    Li, Y.
    Cook, W.
    Hirshberg, B.
    Iqbal, N.
    Rosenstock, J.
    [J]. DIABETOLOGIA, 2014, 57 : S8 - S8
  • [30] Efficacy and safety of dapagliflozin or dapagliflozin plus saxagliptin versus glimepiride as add-on to metformin in patients with type 2 diabetes
    Mueller-Wieland, Dirk
    Kellerer, Monika
    Cypryk, Katarzyna
    Skripova, Dasa
    Rohwedder, Katja
    Johnsson, Eva
    Garcia-Sanchez, Ricardo
    Kurlyandskaya, Raisa
    Sjostrom, C. David
    Jacob, Stephan
    Seufert, Jochen
    Dronamraju, Nalina
    Csomos, Katalin
    [J]. DIABETES OBESITY & METABOLISM, 2018, 20 (11): : 2598 - 2607
12345